Safe magnetic resonance imaging on biocompatible nanoformulations

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Medical Imaging

Background:

• Magnetic Resonance Imaging (MRI) is vital for disease diagnosis but often requires contrast agents.
• Current nanomaterial (NM)-based contrast agents (CAs) face limitations due to toxicity and poor biocompatibility.
• There is a significant need for non-toxic, biocompatible CAs for clinical MRI applications.

Purpose of the Study:

• To review surface coating strategies for creating biocompatible nanomaterials (NMs) for MRI contrast agents.
• To discuss advances and future prospects in developing safe and effective MRI imaging agents.
• To summarize existing literature on biocompatible NMs specifically for MR imaging.

Main Methods:

• Review of scientific literature on nanomaterial surface modification for MRI contrast enhancement.
• Analysis of various surface coating strategies including polymers, proteins, and cell membranes.
• Evaluation of biocompatibility, biodistribution, and imaging capabilities of modified NMs.

Main Results:

• Surface coating strategies significantly improve NM biocompatibility and reduce toxicity.
• Biomimetic approaches enhance blood circulation time and in vivo performance.
• Coated NMs demonstrate high contrast ability for efficient MRI.

Conclusions:

• Surface modification is key to developing safe and effective biocompatible nanomaterial contrast agents for MRI.
• Further research into advanced coating techniques promises improved diagnostic capabilities and patient outcomes.
• This review provides a comprehensive overview of strategies for safe MRI contrast agent development.